Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors

HUMIRA (adalimumab)A Biologic Medication

3 days ago

Bookmark

Share

HUMIRA (adalimumab)A Biologic Medication is a company. It is part of the Health Care sector.

Key facts

sector: Health Care

Classified as: organization

Business

HUMIRA (adalimumab)A Biologic Medication is one of the companies in Health Care and 3,466,499 companies in our database.

Employees: Try Pro to see estimates
Revenues: Try Pro to see estimates

Stocks from HUMIRA (adalimumab)A Biologic Medication:

Talking Points:

HUMIRA® (adalimumab)A Biologic Medication
Find information about HUMIRA® (adalimumab), a biologic medication. See Important Safety Information, including BOXED WARNING.

Learn more about talking points

In literature

There is no book written about HUMIRA (adalimumab)A Biologic Medication in the database

Related

Connected or similar:

Details

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter

This content can be used under the CC BY 4.0 license